High MCM7 expression was correlated with shorter overall survival in several cancers, including hepatocellular carcinoma [8], esophageal squamous cell carcinoma [44], and liver cancer [45], highlighting its potential as a prognostic and predictive biomarker. Here, MCM7 is linked to hepatocellular carcinoma.